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Cocoa polyphenols have antioxidant and anti-inflammatory effects. TNF-a is a pro-inflammatory cytokine that has a vital role in the pathogenesis
of inflammatory diseases such as cancer and psoriasis. Vascular endothelial growth factor (VEGF) expression is associated with tumorigenesis,
CVD, rheumatoid arthritis and psoriasis. We tested whether cocoa polyphenol extract (CPE) inhibited TNF-a-induced VEGF expression in
promotion-sensitive JB6 mouse epidermal cells. CPE significantly inhibited TNF-a-induced up-regulation of VEGF via reducing TNF-a-induced
activation of the nuclear transcription factors activator protein-1 (AP-1) and NF-kB, which are key regulators of VEGF expression. CPE also
inhibited TNF-a-induced phosphorylation of protein kinase B (Akt) and extracellular signal-regulated kinase. CPE blocked activation of their
downstream kinases, p70 kDa ribosomal protein S6 kinase and p90 kDa ribosomal protein S6 kinase. CPE suppressed phosphoinositide
3-kinase (PI3K) activity via binding PI3K directly. CPE did not affect TNF-a-induced phosphorylation of mitogen-activated protein
kinase kinase-1 (MEK1) but suppressed TNF-a-induced MEK1 activity. Collectively, these results indicate that CPE reduced TNF-a-induced
up-regulation of VEGF by directly inhibiting PI3K and MEK1 activities, which may contribute to its chemopreventive potential.
Cocoa polyphenols: Phosphoinositide 3-kinase: Mitogen-activated protein kinase kinase-1: TNF-a: Vascular endothelial growth factor
TNF-a is a 17 kDa protein consisting of 156 amino acids
which acts as a cellular mediator provoking inflammation, pro-
liferation, tumorigenesis and even apoptosis(1). This cytokine
plays a key role in the pathogenesis of diseases such as
cancer, rheumatoid arthritis, Crohn’s disease, diabetes and
psoriasis(2). TNF-a binds with TNF receptor I (p55 receptor)
or II (p75 receptor) and associates with adaptor proteins
to trigger downstream kinases such as phosphoinositide
3-kinase (PI3K)–protein kinase B (Akt) and mitogen-activated
protein kinases. Many inflammatory proteins are expressed
through activation of transcription factors such as activator
protein-1 (AP-1) and NF-kB by upstream signalling. Therefore,
inhibition of the TNF-a signalling pathway may help prevent
these diseases(3).
Vascular endothelial growth factor (VEGF) is a multi-
functional cytokine that is a key regulator of angiogenesis(4).
VEGF expression is associated with the pathology of
tumorigenesis, CVD, rheumatoid arthritis and psoriasis.
Tumour cells require blood vessels because of nutrient and
oxygen deficiency, and VEGF promotes tumour cell survival
via angiogenesis. VEGF is involved in tumour progression
by controlling angiogenesis as well as tumour promotion.
The Ha-ras gene mutation in a chemical-induced two-stage
carcinogenesis model has been shown to enhance VEGF
expression and benign papilloma development(5). Therefore,
inhibition of VEGF expression might be a promising approach
to protect against carcinogenesis.
Cocoa contains high amounts of polyphenols(6) and
contributes to a healthy life through strong antioxidant and
anti-inflammatory activities and a increase of NO bioavailabil-
ity(7,8). Recently, the health benefits of dark chocolate with
reduced energy and an increased proportion of cocoa were
revealed(9). Our previous studies show that cocoa contains
more polyphenols and a higher antioxidant capacity than tea
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and red wine(10). It exerted protective effects against H2O2-
induced inhibition of gap junction intercellular communication
in rat epithelial cells(11) and cocoa polyphenol extract (CPE)
inhibited phorbol ester-induced inflammation through suppres-
sion of cyclo-oxygenase-2 expression in mouse skin(12).
Recently, we reported that CPE inhibits thrombin-induced
expression and activation of matrix metalloproteinase-2
(MMP-2) in vascular smooth muscle cells and phorbol ester-
induced neoplastic transformation of promotion-sensitive
(Pþ) JB6 mouse epidermal cells through direct inhibition of
mitogen-activated protein kinase kinase-1 (MEK1)(13,14).
However, the chemopreventive effects of cocoa involve
mechanisms besides the inhibition of MEK1. Here, we
tested whether cocoa polyphenols inhibit TNF-a-induced
VEGF expression and we suggested a novel molecular target
of CPE, PI3K.
Materials and methods
Chemicals
Eagle’s minimum essential medium (MEM), gentamicin,
fetal bovine serum (FBS) and L-glutamine were purchased
from GIBCO BRL (Carlsbad, CA, USA). TNF-a was
purchased from ProSpec-Tany TechnoGene (Rehovot,
Israel). The ELISA kit for VEGF was purchased from R&D
Systems (Minneapolis, MN, USA). The antibodies against
phosphorylated (p-) MEK (Ser217/221), total extracellular
signal-regulated kinase (ERK), p-p90 kDa ribosomal S6
kinases (p90RSK; Thr359/Ser363), total p90RSK, p-p70 kDa
ribosomal protein S6 kinase (p70S6K; Thr389) and total
p70S6K were obtained from Cell Signaling Biotechnology
(Beverly, MA, USA). p-Akt (Ser 473), p-ERK (Thr202/
Tyr204), total ERK and total MEK1 were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA, USA). The
MEK1 activity assay kit and PI3K active protein were
purchased from Upstate Biotechnology (Lake Placid, NY,
USA). CNBr-Sepharose 4B, glutathione-Sepharose 4B and
[g-32P]ATP were from GE Healthcare (Piscataway, NJ,
USA), and the protein assay kit was purchased from Bio-
Rad Laboratories (Hercules, CA, USA). G418 and the lucifer-
ase assay substrate were from Promega (Madison, WI, USA).
Cell culture
The JB6 Pþ mouse epidermal cell lines were cultured in
monolayers in 5 % FBS–MEM, 1000 units of penicillin and
1 mg/ml of streptomycin at 378C in a 5 % CO2 incubator.
The JB6 mouse epidermal cell line stably transfected with
dominant negative p85 (DN-p85), NF-kB, and AP-1 luciferase
reporter plasmid was a gift from Dr Zigang Dong(15) and
maintained in 5 % FBS–MEM and 200mg/ml G418.
Preparation of cocoa polyphenol extract
Cocoa polyphenols were extracted from commercial cocoa
powder (50 g) produced by LOTTE Confectionery Co. Ltd
(Seoul, Korea) with 500 ml of 50 % (v/v) aqueous ethanol
under reflux for 6 h. After the extraction, the solution was
filtered twice to collect the extract. The collected cocoa extract
was loaded onto a styrene-based adsorption resin column
(60 £ 450 mm, HP-20; Mitsubishi Chemical Co., Tokyo,
Japan), washed with 20 % (v/v) aqueous ethanol, and then
eluted with 60 % (v/v) aqueous ethanol. The eluted CPE
was concentrated at 508C under reduced pressure, frozen,
and dried.
Determination of vascular endothelial growth factor
production
JB6 Pþ cells (5 £ 103) were cultured in ninety-six wells and
incubated for 48 h. After incubation, the cells were pretreated
with CPE at the indicated concentrations for 1 h before incu-
bation with TNF-a (4 ng/ml) for 18 h, and then the culture
medium was harvested. VEGF was quantified according to
the manufacturer’s instructions.
Measurement of cell viability
Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) assay, which is
based on the ability of live cells to convert tetrazolium salt
into purple formazan. JB6 Pþ cells (5 £ 103) were cultured
in ninety-six wells and incubated for 48 h. After incubation,
the cells were pretreated with CPE at the indicated concen-
trations for 1 h before incubation with TNF-a (4 ng/ml) for
18 h, followed by the addition of 20ml MTT stock solution
(5 mg/ml; Sigma, St Louis, MO, USA) to each well and the
plates were further incubated for 4 h at 378C. The supernatant
fraction was removed and 200ml dimethyl sulfoxide was
added to each well to solubilise the water-insoluble purple
formazan crystals. The absorbency at the wavelength of
570 nm was measured with a microplate reader (Molecular
Devices, Sunnyvale, CA, USA). All the measurements were
performed in triplicate. Results are expressed as the percen-
tage proliferation with respect to untreated cells.
Luciferase assay for NF-kB and activator protein-1
transcription activity
Confluent monolayers of JB6 Pþ cells stably transfected with
an AP-1 or NF-kB luciferase reporter plasmid were trypsi-
nised, and 5 £ 103 viable cells suspended in 100ml 5 %
FBS–MEM was added to each well of a ninety-six-well
plate. Plates were incubated at 378C in a humidified atmos-
phere of 5 % CO2. When cells reached 80–90 % confluence,
they were starved by culturing them in 0·1 % FBS–MEM
for another 24 h. The cells were then treated for 15 min with
CPE and exposed to TNF-a (4 ng/ml) for an additional 4 h.
After treatment, cells were disrupted with 100ml lysis buffer
(0·1 M-potassium phosphate buffer (pH 7·8); 1 % Triton
X-100; 1 mM-dithiothreitol (DTT); 2 mM-EDTA), and the
luciferase activity was measured using a luminometer (Micro-
lumat Plus LB 96V; Berthold Technologies, Bad Wildbach,
Germany).
Western blotting analysis
After JB6 Pþ cells (1·0 £ 106) were cultured in a 10 cm dia-
meter dish for 48 h, they were starved in serum-free medium
for another 24 h to eliminate the influence of FBS on the
activation of kinases. The cells were then treated with CPE
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(0–20mg/ml) for 1 h before being exposed to TNF-a (4 ng/ml)
for 15 min. After centrifugation, cell lysis was performed at
48C for 30 min in cell lysis buffer (20 mM-2-amino-2-hydroxy-
methyl-propane-1,3-diol (Tris)-HCl (pH 7·5), 150 mM-NaCl,
1 mM-Na2EDTA, 1 mM-ethylene-glycol-bis(a-aminoethyl)-N,
N,N0,N0-tetra-acetic acid (EGTA), 1 % Triton, 2·5 mM-sodium
pyrophosphate, 1 mM-b-glycerophosphate, 1 mM-Na3VO4,
leupeptin (1mg/ml) and 1 mM-phenylmethanesulfonyl fluoride
(PMSF)). The cell lysates were centrifuged at 23 000 g for
15 min, and the resulting supernatant fraction was stored at
2708C before Western blot analysis. The protein concen-
tration in each sample was measured by subjecting lysate
protein (30mg) to 10 % SDS-PAGE, with the protein
electrophoretically transferred to a nitrocellulose membrane
(Whatman, Clifton, NJ, USA). Protein bands were visualised
by a chemiluminescence detection kit (Amersham, Piscat-
away, NJ, USA) after hybridisation with the horseradish
peroxidase-conjugated secondary antibody. Quantification of
band intensity was measured using Image J software (National
Institutes of Health, Bethesda, MD, USA).
Mitogen-activated protein kinase kinase-1
immunoprecipitation and activity assay
JB6 Pþ cells were cultured to 80 % confluence and then
serum-starved in 0·1 % FBS–MEM for 24 h at 378C. Cells
were either treated or not treated with CPE (0–20mg/ml)
for 1 h before being exposed to TNF-a (4 ng/ml) for 15 min,
disrupted with lysis buffer (20 mM-Tris–HCl (pH 7·4),
1 mM-EDTA, 150 mM-NaCl, 1 mM-EGTA, 1 % Triton X-100,
1 mM-b-glycerophosphate, leupeptin (1 mg/ml), 1 mM-
Na3VO4 and 1 mM-phenylmethylsulfonyl fluoride), and finally
centrifuged at 16 000 g for 10 min in a microcentrifuge. The
lysates containing 500mg protein were used for immunopreci-
pitation with an antibody against MEK1 and incubated at 48C
overnight. Protein A/G Plus agarose beads were then added
and the mixture was continuously rotated for another 3 h at
48C. The beads were washed three times with kinase buffer
(20 mM-3-(N-morpholino)propanesulfonic acid (MOPS; pH
7·2), 25 mM-b-glycerol phosphate, 5 mM-EGTA, 1 mM-
sodium orthovanadate and 1 mM-DTT), and then re-suspended
in 20ml of 1 £ kinase buffer supplemented with 1mg of inac-
tive ERK2 and incubated for an additional 30 min at 308C.
Then myelin basic protein (20mg) and 10ml of diluted
[g-32P]ATP solution were added and the mixture was incu-
bated for 10 min at 308C. A 20ml sample was transferred
onto p81 paper and washed three times with 0·75 % phos-
phoric acid for 5 min per wash and once with acetone for
2 min. The radioactive incorporation was determined using a
scintillation counter.
Phosphoinositide 3-kinase activity assay
An active PI3K protein (100 ng) was incubated with CPE
for 10 min at 308C. Then, the mixtures were incubated with
20ml phosphatidylinositol (0·5 mg/ml) (Avanti Polar Lipids,
Alabaster, AL, USA) for 5 min at room temperature, followed
by incubation with reaction buffer (100 mM-HEPES (pH 7·6),
50 mM-MgCl2, 250mM-ATP containing 0·37 MBq (10mCi) of
[g-32P]ATP) for an additional 10 min at 308C. The reaction
was stopped by adding 15ml of 4 M-HCl and 130ml
chloroform–methanol (1:1, v/v). After vortexing, 30ml of
the lower chloroform phase was spotted onto a 1 % potassium
oxalate-coated silica gel plate that was previously activated for
1 h at 1108C. The resulting 32P-labelled phosphatidylinositol-
3-phosphate was separated by TLC and radiolabelled spots
were visualised by autoradiography.
Pull-down assay
Cell lysates of the TNF-a-treated cells used in the kinase
assay (500mg) or PI3K protein (2mg) were incubated with
CPE–Sepharose 4B (or Sepharose 4B alone as a control)
beads (100ml, 50 % slurry) in reaction buffer comprising
50 mM-Tris-HCl (pH 7·5), 5 mM-EDTA, 150 mM-NaCl,
1 mM-DTT, 0·01 % Nonidet P-40, 2mg/ml bovine serum
albumin, 0·02 mM-PMSF and 1 £ protease inhibitor mixture.
After incubation with gentle rocking overnight at 48C, the
beads were washed five times with buffer (50 mM-Tris-HCl
(pH 7·5), 5 mM-EDTA, 150 mM-NaCl, 1 mM-DTT, 0·01 %
Nonidet P-40 and 0·02 mM-PMSF), and proteins bound to
the beads were analysed by immunoblotting.
Statistical analysis
Data are expressed as mean values and standard deviations.
Student’s t test was used for single statistical comparisons,
with a probability value of P,0·05 as the criterion for
statistical significance.
Results
Cocoa polyphenol extract inhibits TNF-a-induced vascular
endothelial growth factor up-regulation in promotion-sensitive
JB6 mouse epidermal cells
JB6 Pþ cells were pretreated for 1 h with different concen-
trations of CPE and then stimulated with TNF-a (4 ng/ml)
for 18 h. TNF-a-induced VEGF expression in JB6 Pþ cells
was determined by ELISA. CPE dose-dependently inhibited
TNF-a-induced VEGF up-regulation (Fig. 1(a)). These effects
were not due to the cytotoxicity of CPE, because CPE up to
20mg/ml has no effect on cell viability (Fig. 1(b)).
Cocoa polyphenol extract suppresses TNF-a-induced
transactivation of NF-kB and activator protein-1 in
promotion-sensitive JB6 mouse epidermal cells
The eukaryotic transcription factors NF-kB and AP-1 are key
regulators of VEGF expression(16). We next examined whether
CPE attenuates TNF-a-induced transactivation of NF-kB and
AP-1 using JB6 Pþ cell lines stably transfected with an NF-kB
and AP-1 luciferase reporter plasmid. Exposure to TNF-a
(4 ng/ml) for 4 h increased NF-kB luciferase activity by
about 2·5-fold compared with the untreated control, and
CPE dose-dependently inhibited these effects (Fig. 2(a)).
TNF-a also increased AP-1 luciferase activity by about
2-fold compared with the untreated control, which was
attenuated by CPE treatment (Fig. 2(b)).
Vascular endothelial growth factor suppression 959
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Effects of cocoa polyphenol extract on TNF-a-induced
phosphorylation of protein kinase B and mitogen-activated
protein kinase
We next examined the PI3K–Akt and mitogen-activated protein
kinase pathways, which relate to TNF-a-induced NF-kB and
AP-1 transactivation. We investigated the phosphorylation
level of the kinase which is involved in these pathways by
Western blot analysis. CPE suppressed TNF-a-induced phos-
phorylation of Akt, p70S6K, ERK, p90 kDa ribosomal S6
kinase (p90RSK), mitogen-activated protein kinase kinase 4
(MKK4) and c-Jun N-terminal kinase (JNK). Phosphorylation
of MEK was not changed by CPE treatment and phosphorylation
of p38 was increased slightly by CPE treatment (Fig. 3).
Cocoa polyphenol extract suppresses phosphoinositide
3-kinase activity and phosphoinositide 3-kinase is required for
TNF-a-induced vascular endothelial growth factor expression
To elucidate whether CPE blocks the phosphorylation of Akt
and its downstream kinase, p70S6K, to inhibit PI3K activity,
a well-known upstream kinase of Akt, we further examined
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Fig. 1. Effects of cocoa polyphenol extract (CPE) on TNF-a-induced vascular
endothelial growth factor (VEGF) up-regulation in promotion-sensitive (Pþ)
JB6 mouse epidermal cells. (a) Inhibition of TNF-a-induced VEGF
up-regulation in JB6 Pþ cells by CPE. JB6 Pþ cells were treated with CPE at
the indicated concentrations 1 h before treatment with TNF-a at 4 ng/ml for
18 h. The conditioned medium was then collected and analysed by ELISA
as described in Materials and methods. (b) Effect of CPE on JB6 Pþ cell
viability. JB6 Pþ cells were treated with CPE at the indicated concentrations
1 h before treatment with TNF-a at 4 ng/ml for 18 h. Cell viability was
measured by using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay as described in the Materials and methods. Values are
means, with standard deviations represented by vertical bars. Mean value
was significantly different from that of the TNF-a-only-treated cells:
*P,0·05, **P,0·01.
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Fig. 2. Effects of cocoa polyphenol extract (CPE) on TNF-a-induced transac-
tivation of NF-kB and activator protein-1 (AP-1) in promotion-sensitive (Pþ)
JB6 mouse epidermal cells. (a) Inhibition of TNF-a-induced NF-kB activity by
CPE. (b) Inhibition of TNF-a-induced AP-1 activity by CPE. The JB6 Pþ
cells, which were stably transfected with an AP-1 or NF-kB luciferase repor-
ter plasmid, were pretreated with CPE for 1 h at the indicated concentrations
followed by exposure to TNF-a at 4 ng/ml for 4 h. The relative NF-kB and
AP-1 activities were measured by the luciferase assay as described in
Materials and methods. Values are means from three independent exper-
iments, with standard deviations represented by vertical bars. ** Mean value
was significantly different from that of the TNF-a-only-treated cells (P,0·01).
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the effect of CPE on PI3K activity. CPE at 10mg/ml (Fig. 4(a))
completely inhibited PI3K activity. To further confirm the
mechanism of the inhibitory effect of CPE against PI3K activity,
we investigated whether CPE directly binds with PI3K. PI3K
was found in the CPE–Sepharose 4B beads (Fig. 4(b); lane 3),
but not in the Sepharose 4B beads only (Fig. 4(b); lane 2).
Phosphoinositide 3-kinase is required for TNF-a-induced
vascular endothelial growth factor expression
We next examined the involvement of the PI3K signalling
pathway in the TNF-a-induced up-regulation of VEGF in
JB6 Pþ cells. LY294002, a PI3K inhibitor, effectively inhib-
ited TNF-a-induced VEGF up-regulation in JB6 Pþ cells
(Fig. 5(a)). To confirm the role of PI3K in TNF-a-induced
up-regulation of VEGF in JB6 Pþ cells, we used dominant
negative p85 (DN-p85) which is the regulatory domain of
PI3K(17). Compared with mock vector transfected cells,
TNF-a-induced up-regulation of VEGF markedly decreased
in the DN-p85-expressing cells (Fig. 5(b)).
Cocoa polyphenol extract inhibits TNF-a-induced mitogen-
activated protein kinase kinase-1 activity and directly binds
mitogen-activated protein kinase kinase-1
We previously showed that CPE suppressed 12-O-tetradeca-
noylphorbol-13-acetate (TPA)-induced cell transformation
and MMP-2 expression though direct inhibition of MEK
activity(18,19). Similarly here, CPE inhibited TNF-a-induced
phosphorylation of ERK but not MEK. CPE dose-dependently
suppressed TNF-a-induced MEK1 activity in JB6 Pþ cells
(Fig. 6(a)). To further confirm whether CPE directly interacts
with MEK1, we used a CPE pull-down assay. MEK1 in the cell
lysate of TNF-a-treated JB6 Pþ cells bound to the CPE–
Sepharose 4B beads (Fig. 6(b); lane 3), but not to the
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Fig. 3. Effects of cocoa polyphenol extract (CPE) on the TNF-a-induced phosphoinositide 3-kinase (PI3K)–protein kinase B (Akt) and mitogen-activated protein
kinase (MAPK) pathway. (a) Inhibition of TNF-a-induced phosphorylation (p-) of Akt (Akt) and p70 kDa ribosomal protein S6 kinase (p70S6K) by CPE. Promotion-
sensitive (Pþ) JB6 mouse epidermal cells were pretreated with CPE (10 or 20mg/ml) for 1 h, then stimulated with TNF-a at 4 ng/ml and harvested 2 h later.
The levels of phosphorylated and total Akt and p70S6K proteins were determined by Western blot analysis as described in Materials and methods. (b) Inhibition of
TNF-a-induced phosphorylation of extracellular signal-regulated kinase (ERK) and p90 kDa ribosomal S6 kinase (p90RSK) by CPE. Phosphorylation of mitogen-
activated protein kinase kinase (MEK) was not inhibited by CPE. (c) Inhibition of TNF-a-induced phosphorylation of mitogen-activated protein kinase kinase 4
(MKK4) and c-Jun N-terminal kinase (JNK) by CPE. (d) CPE did not inhibit the TNF-a-induced phosphorylation of p38. JB6 Pþ cells were pretreated with CPE
(10 or 20mg/ml) for 1 h, then stimulated with TNF-a at 4 ng/ml and harvested 15 min later. The levels of phosphorylated and total MEK, ERK and p90RSK proteins
were determined by Western blot analysis as described in Materials and methods. Quantification of phosphoproteins was normalised to total proteins using Image
J software (National Institutes of Health, Bethesda, MD, USA).
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Sepharose 4B beads alone (Fig. 6(b); lane 2), indicating that
CPE could directly bind to MEK1 and inhibit MEK1 activity.
Discussion
TNF-a is a key regulator of inflammation and plays vital roles
in inflammatory diseases such as cancer, rheumatoid arthritis,
Crohn’s disease, diabetes and psoriasis. TNF-a induces the
anchorage-independent growth of mouse epidermal JB6 Pþ
cells(20). Knockout mice (TNF-a 2 /2 ) are more resistant to
TPA-induced skin tumour promotion than wild-type
mice(21,22). Neutralising TNF-a with an antibody also inhibits
the development of skin tumours(23). These results suggest that
targeting TNF-a signalling can be an important strategy for
delaying the promotion of skin tumours.
Cocoa contains large amount of flavonoids. It comprises
mainly catechins, flavonol glycosides and procyanidins. Our
previous study using the identical CPE shows that the CPE
had 413 mg epicatechin equivalent flavonoids per g. This
demonstrates that 40 % of CPE is comprised of flavonoids(13).
We suggested that flavonoids can act as PI3K and MEK
inhibitors(15,24,25). Therefore, inhibitory effects of CPE on
PI3K and MEK activity could be due to flavonoids contained
in CPE.
When individuals consume dark chocolate, the substances
epicatechin, catechin, procyanidin B2 or procyanidin B2
gallate are detected in their plasma(26). In a recent clinical
study, 45 g dark chocolate containing up to 70 % cocoa was
fed to human volunteers. Plasma epicatechin concentration
of the volunteers was raised up to 155 ng/ml(27). In this
study only epicatechin concentration was measured. However,
chocolate is comprised of many other flavonoids(28). The sum
of flavonoid concentration would be much higher than that of
epicatechin only. The CPE used in the present study was
effective, starting from 5mg/ml. Therefore, the concentration
(5 to 20mg/ml) of CPE which we used in the present study
seems to be a reliable dose.
In the present study, we found that CPE (5 to 20mg/ml)
dose-dependently inhibited TNF-a-induced VEGF expre-
ssion in JB6 Pþ cells. Cocoa polyphenols exhibit free
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Fig. 4. Direct inhibition of phosphoinositide 3-kinase (PI3K) by cocoa polyphe-
nol extract (CPE). (a) CPE strongly suppresses PI3K activity. A quantity of
100 ng of an active PI3K protein was preincubated with CPE for 10 min at
308C, and then further incubated with phosphatidylinositol substrate and
[g-32P]ATP for an additional 10 min at 308C. The resulting 32P-labelled phos-
phatidylinositol-3-phosphate (PIP3) was measured as described in Materials
and methods. Quantification of PIP3 was performed using Image J software
(National Institutes of Health, Bethesda, MD, USA). (b) CPE specifically binds
to PI3K. PI3K–CPE binding was confirmed by immunoblotting using an anti-
body against PI3K. Lane 1, p110 protein standard served as an input control;
lane 2, as a negative control, Sepharose 4B was used to pull down p110; lane
3, p110 was pulled down using CPE–Sepharose 4B affinity beads.
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Fig. 5. Activation of phosphoinositide 3-kinase (PI3K) is required for TNF-a-
induced vascular endothelial growth factor (VEGF) expression. Promotion-
sensitive (Pþ) JB6 mouse epidermal cells were seeded into ninety-six-well
plates, cultured to 70–80 % confluence with 5 % fetal bovine serum–Eagle’s
minimum essential medium (FBS–MEM), and then starved by replacing the
medium with 0·1 % FBS–MEM for 24 h. The cells were then treated with the
PI3K inhibitor, LY294002 (a), for 1 h before treatment with TNF-a at 4 ng/ml
for 18 h. The conditioned medium was collected and analysed for VEGF
expression using ELISA as described in the Materials and methods. Values
are means, with standard deviations represented by vertical bars. ** Mean
value was significantly different from that of the TNF-a-only-treated cells
(P,0·01). (b) Cell lines stably expressing empty vector (MOCK) or a domi-
nant-negative mutant of p85 (DN-p85) were seeded into ninety-six-well
plates, cultured to 70–80 % confluence with 5 % FBS–MEM, and then
starved by replacing the medium with 0·1 % FBS–MEM for 24 h. The cells
were then treated with TNF-a at 4 ng/ml for 18 h. The conditioned medium
was collected and analysed for VEGF expression using ELISA as described
in the Materials and methods. Values are means, with standard deviations
represented by vertical bars. ** Mean value was significantly different from
that of the TNF-treated MOCK cells (P,0·01).
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radical-scavenging activity, as determined by both 2,20-azino-
bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) and
2,2-diphenyl-1-picrylhydrazyl (DPPH) radical-scavenging
assays and anti-inflammatory effects in mouse skin(12).
Cocoa polyphenols also suppressed the growth of Caco-2
human colon cancer cells through a blockade of the cell
cycle at the G2/M phase(29). Further, cocoa polyphenols
suppressed lung and pancreatic tumorigenesis in a male rat
multi-organ carcinogenesis model(29,30), and TPA-induced
tumour promotion in a mouse two-stage skin tumorigenesis
model initiated with 7,12-dimethylbenz[a ]anthrathene(31).
Thus, the present results support the chemopreventive poten-
tial of cocoa polyphenols.
NF-kB and AP-1 are important transcription factors in
tumour promotion and are activated by many cytokines and
chemicals, including TNF-a(32), leading to VEGF transcrip-
tion(33). VEGF mRNA expression in MDA-MB-231 breast
cancer cells is associated with NF-kB activation(34). AP-1
regulated by ERK or Akt also mediates VEGF expression(35,36).
In the present study the CPE suppressed TNF-a-induced NF-kB
and AP-1 transactivation to block VEGF transcription.
The antioxidant effects of CPE may partially contribute
to these effects, but it may also target other signalling
molecules(37). Some small molecules in food such as
flavonoids also inhibit signalling molecules directly(16,38 – 40).
Targeting PI3K or mitogen-activated protein kinase (ERK,
JNK and p38) pathways is a good strategy for cancer preven-
tion. PI3K phosphorylates the 3 position of the hydroxyl group
of the inositol ring of phosphatidylinositol and controls
cellular processes such as cell proliferation and apoptosis.
It is activated in many tumours and small molecule inhibitors
are being developed(41). In the present study the CPE strongly
suppressed PI3K activity and bound PI3K directly. These
results explain the inhibition of pAkt and p70S6K, which are
downstream kinases of PI3K.
Our previous studies demonstrated that CPE inhibited TPA-
induced neoplasmic transformation in mouse epidermal cells and
suppressed thrombin-induced MMP-2 activation through direct
inhibition of MEK1 activity(18,19). A pharmacological inhibitor
of MEK suppressed TNF-a-induced VEGF expression in JB6
Pþ cells(42). CPE attenuated TNF-a-induced MEK1 activity,
and subsequently phosphorylation of ERK, without affecting
MEK phosphorylation. Therefore, inhibition of MEK1 contributes
to inhibition of TNF-a-induced VEGF expression by CPE.
Our previous study showed that the MKK4–JNK pathway is
required for TNF-a-induced VEGF expression using specific
inhibitors(42). In the present study the CPE inhibited TNF-a-
induced phosphorylation of MKK4 and JNK. However, MEK1
and PI3K, which are revealed as targets of the CPE in the present
study, cannot explain the phenomenon of inhibition on the
MKK4–JNK pathway by the CPE. Increase of p38 phosphoryl-
ation is also hard to explain with MEK1 and PI3K inhibition.
Further study must reveal new target proteins of CPE which
control the TNF-a-induced MKK4–JNK and p38 pathway.
Multi-target kinase inhibitors have significant side effects.
However, they are in the spotlight since the success of
Gleevec targeting Bcr-Abl and KIT kinase due to its powerful
effect and a variety of applications(43). Food materials are
usually regarded as safe because of their long-term use. There-
fore, multi-targeting may be better than specific targeting
for food materials. In summary, a CPE suppressed TNF-
a-induced VEGF expression via targeting PI3K and MEK1
to inhibit phosphorylation of ERK and Akt in mouse epidermal
cells. Taken together, these results indicated that CPE might
have chemopreventive potential against pro-inflammatory
cytokine-mediated skin cancer and inflammation.
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